Long-term Outcome of Adjuvant Chemotherapy with MVP-CAB Regimen (Methotrexate, Vincristine, Cisplatin, Cyclophosphamide, Adriamycin and Bleomycin) for Locally Advanced Bladder Cancer

By Miyake Hideaki   Sakai Iori   Harada Ken-Ichi   Hara Isao   Eto Hiroshi  

UroOncology, Vol. 4, Iss. 3-4, 2004-09 ,pp. : 151-156

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Phase I and pharmacodynamic study of vorinostat combined with capecitabine and cisplatin as first-line chemotherapy in advanced gastric cancer

By Yoo Changhoon   Ryu Min-Hee   Na Young-Soon   Ryoo Baek-Yeol   Lee Chae-Won   Maeng Jeheon   Kim Se-Yeon   Koo Dong   Park Inkeun   Kang Yoon-Koo  

Investigational New Drugs, Vol. 32, Iss. 2, 2014-04 ,pp. : 271-278

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of rubitecan, an oral camptothecin in patients with advanced colorectal cancer who have failed previous 5-fluorouracil based chemotherapy

By Patel Hitendra   Stoller Ronald   Auber Miklos   Potter Douglas   Cai Chao   Zamboni William   Kiefer Gauri   Matin Khalid   Schmotzer Amy   Ramanathan Ramesh  

Investigational New Drugs, Vol. 24, Iss. 4, 2006-07 ,pp. : 359-363

Springer Publishing Company

Access to resources Recommend Favorite

Sequence-specific toxicity with chemotherapy

By  

Reactions Weekly, Vol. 1, Iss. 1214, 2008-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Sequence-specific toxicity with chemotherapy

By  

Inpharma, Vol. 1, Iss. 1650, 2008-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite